WT
AGN

Washington Trust’s Allergan plc AGN Stock Holding History

Washington Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-138
Closed -$25K – 1045
2020
Q1 		$25K Buy
+138
New +$26K ﹤0.01% 513
2018
Q3 		– Sell
-129
Closed -$22K – 928
2018
Q2 		$22K Buy
+129
New +$20.7K ﹤0.01% 567
2017
Q1 		– Sell
-3,451
Closed -$725K – 218
2016
Q4 		$725K Sell
3,451
-54,000
-94% -$11.2M 0.05% 125
2016
Q3 		$13.2M Sell
57,451
-1,847
-3% -$451K 0.87% 46
2016
Q2 		$13.7M Buy
59,298
+1,781
+3% +$411K 0.93% 42
2016
Q1 		$15.4M Buy
57,517
+4,093
+8% +$1.17M 1.03% 39
2015
Q4 		$16.7M Buy
53,424
+20,194
+61% +$6.01M 1.14% 36
2015
Q3 		$9.03M Buy
+33,230
New +$10.2M 0.65% 56
2015
Q2 		– Sell
-689
Closed -$204K – 219
2015
Q1 		$204K Buy
+689
New +$196K 0.01% 206

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Washington Trust's AGN Position: Q2 2020 in Review

Washington Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 138 shares — an estimated $25K sold.

Washington Trust first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $16.7M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Washington Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Washington Trust sold 138 Allergan plc shares in Q2 2020, an estimated $25K.
  • Washington Trust first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Washington Trust's Allergan plc position peaked at $16.7M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Washington Trust's 13F filing for Q2 2020, filed 4 Aug 2020.